Paul R. Hutson

Single-Dose Psilocybin Treatment for Major Depressive Disorder

Charles L. Raison, Gerard Sanacora, Joshua Woolley et al. · JAMA · 2023 · 484 citations · Full text

Medicine, Pharmacology, Psychiatry +11

Phase II study of topotecan in patients with extensive-stage small-cell carcinoma of the lung: an Eastern Cooperative Oncology Group Trial.

Joan H. Schiller, K Kim, Paul R. Hutson et al. · Journal of Clinical Oncology · 1996 · 210 citations

Medicine, Oncology, Pharmacology +16

Beta-lapachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: a p53-independent response.

Sarah M. Planchon, Shelly M. Wuerzberger, Benjamín Frydman et al. · PubMed · 1995 · 205 citations · Full text

Medicine, Oncology, Pharmacology +17

Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults

Randall Brown, Christopher R. Nicholas, Nicholas V. Cozzi et al. · Clinical Pharmacokinetics · 2017 · 188 citations

Medicine, Pharmacokinetics, Pharmacology +7

Phase I Trial of a Novel Anti-GD2 Monoclonal Antibody, Hu14.18K322A, Designed to Decrease Toxicity in Children With Refractory or Recurrent Neuroblastoma

Fariba Navid, Paul M. Sondel, Raymond Barfield et al. · Journal of Clinical Oncology · 2014 · 164 citations · Full text

Pharmacy, Oncology, Pharmacokinetics +17